Ross Marowits, The Canadian Press

Ross Marowits is a reporter with The Canadian Press, a national news agency headquartered in Toronto and founded in 1917.

BoC rate hike contributes to loonie falling to a 20-month low

Investors fear the Federal Reserve will mirror the full percentage point hike in two weeks

By Ross Marowits, The Canadian Press |July 14, 2022

2 min read

Threat of stagflation challenging for investors to stickhandle

Experts suggest tactical approach, real assets, alternatives

By Ross Marowits, The Canadian Press |June 2, 2022

4 min read

Recession signal could prompt portfolio rebalance

Investor concerns surfaced in recent weeks after U.S. yield curve inversions

By Ross Marowits, The Canadian Press |April 7, 2022

4 min read

Donation of shares increases in popularity after strong market gains

Securities donations including stocks, bonds and mutual funds rose by 52% in the past year, CanadaHelps says

By Ross Marowits, The Canadian Press |December 16, 2021

4 min read

Canadian business community largely supportive of vaccine passport system

Quebec will require proof of vaccination to access non-essential services where Covid-19 transmission is high

By Ross Marowits, The Canadian Press |August 9, 2021

4 min read

Canada to tax tech giants as planned despite G7 tax deal, says Freeland

G7 finance ministers agreed to a global minimum corporate tax of at least 15%

By Ross Marowits, The Canadian Press |June 7, 2021

4 min read

Overheated stock market at risk of bubble in a disconnect from economy, experts say

The S&P/TSX composite is up 65% from March 2020 lows

By Ross Marowits, The Canadian Press |February 16, 2021

5 min read

Investors look with optimism to ‘year of the vaccine’

An expected recovery in commodities and financials next year could disproportionately benefit the Canadian market

By Ross Marowits, The Canadian Press |December 21, 2020

5 min read

As vaccine rollouts begin, investors weigh risks and rewards of biotech sector

For the most part, Canadian investors have to turn to the U.S. to access pharmaceutical efforts to combat Covid

By Ross Marowits, The Canadian Press |December 7, 2020

4 min read